pharma · Hemophilia A With Inhibitor · Hemophilia A · CPRX
CATALYST PHARMACEUTICALS
CATALYST PHARMACEUTICALS, INC.
CATALYST PHARMACEUTICALS trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US HQ
2002 Founded
179 Employees
Public company Type
CPRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US
- Founded
- 2002
- Employees
- 179
- Programs
- 23
- Drugs
- 20
- Patents
- 61
CATALYST PHARMACEUTICALS clinical trials
Registry index of 25 ClinicalTrials.gov studies linked to CATALYST PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.
CATALYST PHARMACEUTICALS trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CATALYST PHARMACEUTICALS.
-
vigabatrin — Phase 2
Clinical update -
HWK-016, MUCIN-16-targeted ADC — Phase 1
Clinical update -
Dupilumab — Phase 2
Clinical update -
CPP-109 vigabatrin — Phase 2
Clinical update -
Coagulation Factor VIIa variant — Phase 2
Clinical update -
amifampridine phosphate — Phase 3
Clinical update -
Amifampridine Phosphate — Phase 3
Clinical update -
Amifampridine Phosphate — Phase 3
Clinical update